Menu Back toSession 6: eLabeling in Latin America is This Concept a Possible Reality?

Latin America Regulatory Conference

Session 6: eLabeling in Latin America is This Concept a Possible Reality?

Session Chair(s)

Maria Cristina  Mota Pina, MBA

Maria Cristina Mota Pina, MBA

  • Director, Regulatory Policy and Intelligence -Japan, Emerging Markets, Australia
  • AbbVie, Inc., United States
This session will discuss the concept of eLabelling, the potential benefits that the initiative could provide to different stakeholders (patient, industry, regulators, health care professionals) How different regulators globally are implementing this concept and the opportunities for the Latin America Region.
Learning Objective : At the conclusion of this session, participants should be able to:
  • Understand the concept of e labeling and potential benefits
  • Initiatives that are currently ongoing in the region
  • Discuss the opportunities that this initiative could bring to the region


Aimad  Torqui

eLabelling as a Tool for Enhancing Patient Care

Aimad Torqui

  • Executive Director Global Regulatory Policy
  • MSD`, Netherlands
Márcia  De Oliveira

Labeling Considerations

Márcia De Oliveira

  • Coordinator of Package Insert, Labeling, Simplified Registration and Trade Name
  • Agência Nacional De Vigilância Sanitária, Brazil
Erika  Rufino, MBA

eLabeling as Digital Transformation in Brazil

Erika Rufino, MBA

  • Regulatory Affairs Senior Manager
  • Janssen Pharmaceuticals, Brazil

Contact us

Registration Questions?

Send Email

On Demand Content Preview Webinar

Registration Pathways to Accelerate Regulatory Assessment of Innovative Medicines in Latin America
Register Today!